BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. SPY

Go back to BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates

BioMarin Pharma (BMRN) Reports In-Line Q4 EPS

February 23, 2022 4:07 PM EST

BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $449.8 million versus the consensus estimate of $442.09 million.

GUIDANCE:

BioMarin Pharma sees FY2022 revenue of $2.05-2.15 billion, versus the consensus of... More